221 filings
8-K
ALBT
Avalon GloboCare Corp.
31 Oct 24
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales
9:00am
8-K
ALBT
Avalon GloboCare Corp.
29 Oct 24
Amendments to Articles of Incorporation or Bylaws
5:21pm
8-K
ALBT
Avalon GloboCare Corp.
25 Oct 24
Regulation FD Disclosure
9:00am
8-K
ALBT
Avalon GloboCare Corp.
24 Oct 24
Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan
9:00am
8-K
ALBT
Avalon GloboCare Corp.
11 Oct 24
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
e9itk
9 Oct 24
Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device
9:00am
NT 10-Q
v34f72a 82gu69
14 Aug 24
Notice of late quarterly filing
5:00pm
8-K
9c85eiujhvldni p9
14 Aug 24
Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device
8:29am
8-K
kb0y9xcbrxk62cz28z
31 Jul 24
Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
8:18am
8-K
ltja1m
18 Jul 24
Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us
8:37am
8-K
r4b9h57 i14j4my0f5vi
16 Jul 24
Changes in Registrant's Certifying Accountant
4:05pm
8-K
vpqqh5 sm8f
5 Jun 24
Entry into a Material Definitive Agreement
4:54pm
8-K
o0xf2
24 May 24
Avalon GloboCare Corp. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
5:10pm
NT 10-Q
7ponxflo2pm47d
15 May 24
Notice of late quarterly filing
8:00am
8-K
j25c95sl22b18
7 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm